Essity

Transaction in Own Shares • May 12, 2025

Press release

Stockholm, May 12, 2025

Buyback of Class B shares in Essity during week 19, 2025

Between May 5, 2025, and May 09, 2025, Essity Aktiebolag (publ) repurchased a total of 259,857 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

The share purchase is part of the SEK 3bn buyback program announced by Essity on April 23, 2025. The buyback program will extend from April 24, 2025, until the 2026 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission's Delegated Regulation 2016/1052 (Safe Harbour Regulation).

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation.

Date	Aggregated daily volume (no. of shares):	Weighted average price per day (SEK):	Total daily transaction value (SEK):
May 5, 2025	51,001	279.1956	14,239,255
May 6, 2025	51,716	277.3795	14,344,958
May 7, 2025	51,981	275.3401	14,312,454
May 8, 2025	52,794	274.5029	14,492,106
May 9, 2025	52,365	273.0292	14,297,174
Total accumulated during week 19 2025	259,857	275.8669	71,685,947
Total accumulated during the buyback program	570,056	274.8206	156,663,132

Class B shares in Essity were repurchased as follows:

All purchases were conducted on Nasdaq Stockholm by BofA Securities Europe SA on behalf of Essity. Following the above purchases, Essity's holding of treasury shares amounted on May 9, 2025, to 1,352,556 Class B shares. The total number of shares in Essity amounted on the date of this press release to 693,054,489, of which 58,973,654 Class A shares and 634,080,835 Class B shares.

For additional information, please contact: Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

About Essity

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2024, Essity had net sales of approximately SEK 146bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.